Addus HomeCare (NASDAQ:ADUS – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $1.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.79 by $0.04, FiscalAI reports. The company had revenue of $387.74 million for the quarter, compared to the consensus estimate of $388.72 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%.
Addus HomeCare Stock Up 0.6%
Shares of ADUS stock traded up $0.80 during trading hours on Tuesday, reaching $126.55. 455,467 shares of the company’s stock were exchanged, compared to its average volume of 236,242. The stock’s fifty day moving average price is $117.10 and its two-hundred day moving average price is $106.54. The stock has a market cap of $2.36 billion, a PE ratio of 22.20, a PEG ratio of 1.74 and a beta of 0.83. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05. Addus HomeCare has a 1 year low of $87.95 and a 1 year high of $127.08.
Analysts Set New Price Targets
Several research firms recently weighed in on ADUS. Raymond James Financial set a $137.00 target price on shares of Addus HomeCare in a research note on Monday, September 28th. Barclays boosted their target price on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a report on Wednesday, July 8th. Royal Bank Of Canada increased their price target on shares of Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Bank of America lowered Addus HomeCare from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $140.00 to $125.00 in a research note on Monday, September 14th. Finally, Citigroup lowered Addus HomeCare from a “market outperform” rating to a “neutral” rating in a report on Monday, September 14th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $129.33.
Addus HomeCare Company Profile
Addus HomeCare Inc (NASDAQ: ADUS) provides in-home personal care, hospice and home health services to older adults, people with disabilities and other individuals who need assistance with daily living or medical care. Its services are designed to help clients remain safely and independently in their homes while supporting families and caregivers.
The company’s personal care services include assistance with bathing, dressing, grooming, meal preparation, housekeeping and other activities of daily living.
Read More
- Five stocks we like better than Addus HomeCare
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
